Business Context and Reporting Period
This Form 8-K filing by AntriaBio, Inc. (not Rezolute, Inc.) reports on events occurring on November 28, 2014. The company completed the initial close of a private placement transaction (PIPE Financing) to raise capital.
Key Financial Metrics
- Net Cash Proceeds: $3 million received after deducting placement agent compensation, transaction costs, fees, and expenses.
- Securities Issued: 1,742,783 Units.
- Unit Price: $1.85 per Unit.
- Unit Composition: One share of common stock and one common share purchase warrant.
- Warrant Terms: Exercise price of $2.50; exercisable for 36 months following the initial close.
- Placement Agent Fees: 10% cash fee on gross proceeds, warrants equal to 17.5% of gross proceeds, and a $25,000 non-accountable expense fee.
Material Changes
The filing details a material definitive agreement involving the issuance of unregistered equity securities. This transaction represents a significant capital infusion event distinct from prior periods, as it marks the completion of the initial close of the PIPE Financing.
Outlook, Risks, and Contingencies
- Regulatory Status: The Units, Offered Shares, and Warrants were not registered under the Securities Act of 1933, relying on exemptions under Section 4(a)(2) and Rule 506 of Regulation D for accredited investors.
- Restrictions: Securities may not be offered or sold in the United States absent registration or an applicable exemption.
- Management Commentary: The filing serves as a Rule 135c notice and does not constitute an offer to sell securities or a solicitation to purchase them.
Investor Verification Checklist
- Verify the total gross proceeds raised before fees to confirm the 10% cash fee and 17.5% warrant fee calculations.
- Confirm the number of shares outstanding post-issuance to assess dilution impact.
- Review the full text of the Warrant (Exhibit 4.1) for specific exercise conditions and anti-dilution provisions.
- Check subsequent filings for the final closing of the PIPE Financing, as this report covers only the "Initial Close."